Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Courtney A. Schreiber"'
Feasibility study of a single‐handed inserter for levonorgestrel 52 mg intrauterine device placement
Autor:
David L. Eisenberg, Courtney A. Schreiber, Paul D. Blumenthal, David K. Turok, Andrea I. Olariu, Mitchell D. Creinin
Publikováno v:
Reproductive, Female and Child Health, Vol 3, Iss 1, Pp n/a-n/a (2024)
Abstract Objective To assess placement outcomes using a levonorgestrel 52 mg intrauterine device (IUD) inserter designed for single‐handed use. Methods Investigators enroled participants 18–45 years to have the IUD inserted using a redesigned ins
Externí odkaz:
https://doaj.org/article/cb1700afc59c4c159506bf2019456326
Autor:
Lynn A. Beer, Suneeta Senapati, Mary D. Sammel, Kurt T. Barnhart, Courtney A. Schreiber, David W. Speicher
Publikováno v:
Reproductive Biology and Endocrinology, Vol 20, Iss 1, Pp 1-18 (2022)
Abstract Background In early pregnancy, differentiating between a normal intrauterine pregnancy (IUP) and abnormal gestations including early pregnancy loss (EPL) or ectopic pregnancy (EP) is a major clinical challenge when ultrasound is not yet diag
Externí odkaz:
https://doaj.org/article/3ffea58e4c764846b9d7f29b2a3914ce
Autor:
David Hubacher, Courtney A. Schreiber, David K. Turok, Jeffrey T. Jensen, Mitchell D. Creinin, Kavita Nanda, Katharine O'Connell White, Ila Dayananda, Stephanie B. Teal, Pai-Lien Chen, Beatrice A. Chen, Alisa B. Goldberg, Jennifer L. Kerns, Clint Dart, Anita L. Nelson, Michael A. Thomas, David F. Archer, Jill E. Brown, Paula M. Castaño, Anne E. Burke, Bliss Kaneshiro, Diana L. Blithe
Publikováno v:
EClinicalMedicine, Vol 51, Iss , Pp 101554- (2022)
Summary: Background: The most widely used copper intrauterine device (IUD) in the world (the TCu380A), and the only product available in many countries, causes side effects and early removals for many users. These problems are exacerbated in nullipar
Externí odkaz:
https://doaj.org/article/db655b0464ca45c6b25f1bc9ab3dd9cb
Publikováno v:
Contraception: X, Vol 2, Iss , Pp 100040- (2020)
Objective: The objective was to describe the sonographic position of copper intrauterine devices (IUDs) 6 months after insertion during cesarean delivery. Study design: This prospective, observational study followed participants who received a copper
Externí odkaz:
https://doaj.org/article/d01a95a5b2aa470db3d77cc67680d28a
Publikováno v:
Obstetrics & Gynecology. 141:219-222
Autor:
Sarita Sonalkar, Arden McAllister, Corinne Kete, Jessica Fishman, Alhambra Frarey, William R. Short, Courtney A. Schreiber, Anne Teitelman
Publikováno v:
J Acquir Immune Defic Syndr
BACKGROUND: Family planning and abortion clinics routinely address sexual health. We sought to evaluate implementation outcomes of an HIV pre-exposure prophylaxis (PrEP) care strategy for patients seeking management of induced abortion and pregnancy
Autor:
Andrea H. ROE, Nathanael KOELPER, Arden MCALLISTER, Kurt T. BARNHART, Courtney A. SCHREIBER, Denis HADJILIADIS
Publikováno v:
Journal of Cystic Fibrosis.
Autor:
Taylor Burger, Joanna Li, Qiuhong Zhao, Courtney A. Schreiber, Stephanie Teal, David K. Turok, Melissa Natavio, Jeffrey F. Peipert
Publikováno v:
Obstetrics & Gynecology. 139:554-560
To assess whether obesity is associated with increased time to pregnancy in a cohort of participants who were stopping their contraceptive method to attempt pregnancy.We performed a secondary analysis of the FACT (Fertility After Contraceptive Termin
Autor:
Anne N. Flynn, Elizabeth Hoffman, Christina Murphy, Alicia Jen, Courtney A. Schreiber, Andrea H. Roe
Publikováno v:
Contraception. 110:27-29
To estimate the rate of requiring more than one 300-mcg Rh D immune globulin dose for fetomaternal hemorrhage (FMH) at the time of second-trimester dilation and evacuation (D + E).We performed a retrospective cohort analysis of patients at greater th
Autor:
Andrea H. Roe, Alice Abernathy, Anne N. Flynn, Arden McAllister, Nathanael C. Koelper, Mary D. Sammel, Courtney A. Schreiber, Sarita Sonalkar
Publikováno v:
Obstet Gynecol
Obstetrics and gynecology, vol 139, iss 6
Obstetrics and gynecology, vol 139, iss 6
Early pregnancy loss can be treated medically with mifepristone followed by misoprostol, with ultrasonographic confirmation of pregnancy expulsion. Alternative strategies that ascertain treatment success remotely are needed. We compared percent decli